We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.57B
AUM Growth
+$240M
Cap. Flow
-$1.33M
Cap. Flow %
-0.05%
Top 10 Hldgs %
34.11%
Holding
1,211
New
84
Increased
525
Reduced
539
Closed
63

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$18.8M
2
LIN icon
Linde
LIN
+$15.3M
3
AVGO icon
Broadcom
AVGO
+$2.95M
4
AMD icon
Advanced Micro Devices
AMD
+$2.59M
5
HD icon
Home Depot
HD
+$1.46M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$6.03M
2
MSFT icon
Microsoft
MSFT
+$5.38M
3
CVX icon
Chevron
CVX
+$4.36M
4
META icon
Meta Platforms (Facebook)
META
+$4.08M
5
AAPL icon
Apple
AAPL
+$3.64M

Sector Composition

Rank Sector Weight
1 Technology 42.5%
2 Healthcare 12.67%
3 Consumer Discretionary 11.07%
4 Communication Services 9.14%
5 Financials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RBLX icon
226
Roblox
RBLX
$34B
$1.51M 0.06%
39,674
+3,927
+11% +$159K
VCEL icon
227
Vericel Corp
VCEL
$2.3B
$1.5M 0.06%
28,845
+9,299
+48% +$408K
ROIV icon
228
Roivant Sciences
ROIV
$25.2B
$1.5M 0.06%
142,347
-1,768
-1% -$19.1K
GFI icon
229
Gold Fields
GFI
$29.2B
$1.5M 0.06%
94,347
+7,776
+9% +$108K
CERE
230
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$1.49M 0.06%
35,234
+11,209
+47% +$471K
RVMD icon
231
Revolution Medicines
RVMD
$40.2B
$1.49M 0.06%
46,114
-14,993
-25% -$444K
RYTM icon
232
Rhythm Pharmaceuticals
RYTM
$7B
$1.49M 0.06%
34,281
+13,790
+67% +$604K
EDU icon
233
New Oriental
EDU
$7.84B
$1.48M 0.06%
17,062
-3,808
-18% -$323K
INCY icon
234
Incyte
INCY
$23.5B
$1.48M 0.06%
25,985
-3,096
-11% -$186K
JNPR
235
DELISTED
Juniper Networks
JNPR
$1.48M 0.06%
39,840
-2,190
-5% -$79.9K
FISV
236
Fiserv Inc
FISV
$27.2B
$1.48M 0.06%
9,235
+1,164
+14% +$170K
BX icon
237
Blackstone
BX
$104B
$1.47M 0.06%
11,209
+1,918
+21% +$240K
MTCH icon
238
Match Group
MTCH
$8.84B
$1.46M 0.06%
40,365
+3,031
+8% +$110K
PCVX icon
239
Vaxcyte
PCVX
$7.89B
$1.46M 0.06%
21,429
-5,851
-21% -$405K
PM icon
240
Philip Morris
PM
$301B
$1.46M 0.06%
15,950
-1,070
-6% -$98.7K
ZM icon
241
Zoom
ZM
$25.8B
$1.46M 0.06%
22,313
+2,881
+15% +$192K
IMVT icon
242
Immunovant
IMVT
$8.09B
$1.45M 0.06%
45,004
+7,544
+20% +$275K
SRPT icon
243
Sarepta Therapeutics
SRPT
$1.66B
$1.45M 0.06%
11,165
-5,112
-31% -$626K
ALPN
244
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.44M 0.06%
36,372
+22,934
+171% +$677K
INSM icon
245
Insmed
INSM
$23.2B
$1.44M 0.06%
52,943
-1,084
-2% -$30.3K
OKTA icon
246
Okta
OKTA
$24.1B
$1.43M 0.06%
13,642
-1,606
-11% -$148K
NTRA icon
247
Natera
NTRA
$37.5B
$1.43M 0.06%
15,594
-8,768
-36% -$659K
AMT icon
248
American Tower
AMT
$77.7B
$1.43M 0.06%
7,214
-730
-9% -$145K
LI icon
249
Li Auto
LI
$12.6B
$1.42M 0.06%
46,826
+33,171
+243% +$1.1M
SWTX
250
DELISTED
SpringWorks Therapeutics
SWTX
$1.41M 0.06%
28,686
+4,247
+17% +$196K
8 9
10
11 12

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Profund Advisors held 1,211 positions worth $2.57B, up 10% from $2.33B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors's Q1 2024 filing shows 84 new, 525 increased, 539 reduced and 63 closed positions. Its largest new stake was Altimmune: 134,842 shares worth $1.37M. The largest sale was ExxonMobil, an estimated $6.03M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Profund Advisors's largest Q1 2024 buy was Altimmune: 134,842 shares worth $1.37M.
  • Profund Advisors added most to NVIDIA in Q1 2024, an estimated $18.8M increase.
  • Profund Advisors's biggest Q1 2024 reduction was ExxonMobil, cutting an estimated $6.03M.
  • Profund Advisors fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $2.18M.
  • Profund Advisors's ten largest holdings make up 34% of its $2.57B portfolio in Q1 2024.
  • Profund Advisors opened 84 new positions and closed 63 in Q1 2024.
  • Profund Advisors's portfolio value rose 10% quarter-over-quarter to $2.57B.

Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.